Sustained-release of oxytetracycline from chitosan microspheres prepared by interfacial acylation and spray hardening methods

Journal of Microencapsulation

Volumn 14, Issue 5, 1997, Pages 577-591

  Fwu Long, Mi ^a   Wong, Tsung Bi ^a   Shyu, Shin Shing ^a  

^a NATIONAL CENTRAL UNIVERSITY   (Taiwan)

Author keywords

Antibiotic agent; Chitosan; Interfacial acylation; Microspheres; Oxytetracycline; Spray hardening

Indexed keywords

CHITOSAN; MICROSPHERE; OXYTETRACYCLINE; TETRACYCLINE DERIVATIVE;

ACYLATION; ARTICLE; INTRAMUSCULAR DRUG ADMINISTRATION; MOLECULAR WEIGHT; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SUSTAINED RELEASE PREPARATION; X RAY ANALYSIS;

EID: 15644383204     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.3109/02652049709006811     Document Type: Article

References (20)

1. AGUIAR, A. J., ARMSTRONG, W. A., and DESAI, S. J., 1987, Development of oxytetracycline long-acting injectable. Journal of Controlled Release, 6, 375-385.
2. AMES, T. R., HYDE, F. W., and MARABELLA, C. P., 1992, Oxytetracycline-containing bovine serum albumin microspheres for treatment of calves with experimentally induced Pasteurella haemolytica pneumonia. Journal of Controlled Release, 22, 219-222.
3. ARMSTRONG, W. A. and MILL, N. Y., 1978, Tetracycline antibiotic composition. US Patent, No. 4126680.
4. ARMSTRONG, W. A. and MILL, N. Y., 1981, Oxytetracycline compositions. US Patent, No. 4259331.
5. BODMEIER, R., OH, K. H. and PRAMAR, Y., 1989, Preparation and evaluation of drug-containing chitosan beads. Drug Development and Industrial Pharmacology, 15, 1475-1494.
6. DAVID, P., MANSSUR, Y. and MARK, S., 1992, Unusual susceptibility of chitosan to enzymic hydrolysis. Carbohydrate Research, 237, 325-332.
7. FISHER, M. C., and ANGELO, M. M., 1994, Tetracycline dosage from. US Patent, No. 5277916.
8. GROBOILLOT, A. F., CHAMPAGNE, C. P., DARLING, G. D., PONCELET, D. and NEUFELD, R. J., 1993, Membrane formation by interfacial cross-linking of chitosan for microencapsulation of lactococcus lactis. Biotechnology and Bioegineering, 42, 1157-1163.
9. HACKE, W. and HORN, H., 1983, Injectable oxytetracycline composition. US Patent, No. 4399127.
10. HASSAN, E. E., PARISH, R. C. and GALLO, J. M., 1992, Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole. Pharmacology Research, 9, 390-397.
11. HIGUCHI, T., 1961, Rate of release of medicaments from ointment base containing drugs in suspension. Journal of Pharmacological Science, 50, 874-875.
12. HIGUCHI, T., 1963, Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs in solid matrices. Journal of Pharmacological Science, 52, 1145-1149.
13. KNORR, D., 1982, Functional properties of chitin and chitosan. Journal of Food Science, 47, 593-595.
14. NISHIOKA, Y., KYOTANI, S., MASUI, H., OKAMURA, M., MIYAZAKI, M., OKAZAKI, K., OHNISHI, S., YAMAMOTO, Y. and ITO, K., 1989, Preparation and release characteristics of cisplatin albumin microspheres containing chitin and treated with chitosan. Chemical and Pharmacological Bulletin, 37(11), 3074-3077.
15. NISHIOKA, Y., KYOTANI, S., OKAMURA, M., MIYAZAKI, M., KAZAKI, K., OHNISHI, S., YAMAMOTO, Y. and ITO, K., 1990, Release characteristics of cisplatin chitosan microspheres and effect of containing chitin. Chemical and Pharmacological Bulletin, 30(10), 2871-2873.
16. OHYA, Y., SHIRATAMI, M. and OUCHI, T., 1994, Release behaviour of 5-FU from chitosan gel nanospheres immobilizing 5-FU coated with polysaccharides. Journal of Macromolecular Science, A31, 629-642.
17. OHYA, Y., TAKEI, T. and OUCHI, T., 1992, Thermo-sensitive release behavior of 5-FU from chitosan-gel microspheres coated with lipid layer. Journal of Bioactive and Compatable Polymers, 7, 242-256.
18. SHIRAISHI, S., IMAI, T. and OTAGIRI, M., 1993, Controlled release of indomethacin by chitosan-polyelectrolyte complex: optimization and in vivo/in vitro evaluation. 25, 217-225.
19. THANOO, B. C., SUNNY, M. S. and JAYAKRISHNAN, A., 1992, Crosslinked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. Journal of Pharmaceutics and Pharmacology, 44,283-286.
20. THOMAS, C. and SHARMA, P., 1990, Chitosan as a biomaterial. Biomaterials, Artificial Cells and Artificial Organs, 18, 1-24.